Paradromics was last valued at $500M. It comes from the Series B of Feb 2025. Paradromics is a public company.
1 valuation. The latest, $500M, was set by the Series B in Feb 2025.
A private valuation is the price agreed in one transaction. The Paradromics valuation of $500M is a private-market figure from the Series B dated 12 Feb 2025 .
The valuation holds until the next priced round or secondary sale. A private company founded in 2015 has no daily price and no order book between rounds.
The closest neurotec peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Yes. Paradromics is a publicly traded company.
The last valuation is $500M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
